Medical and surgical management of symptomatic carotid stenosis

International Journal of Stroke

Volumn 1, Issue 3, 2006, Pages 140-149

  Rothwell, Peter M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Blood pressure; Cartoid stenosis; Endarterectomy; Prevention; SPARCL; Stenting; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN; WARFARIN;

AGE DISTRIBUTION; ANGIOPLASTY; BLEEDING; BLOOD PRESSURE REGULATION; BRAIN BLOOD FLOW; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; DISEASE ACTIVITY; DISEASE SEVERITY; DOSE RESPONSE; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; MONOTHERAPY; PERFUSION PRESSURE; POSTOPERATIVE CARE; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; SEX DIFFERENCE; SIDE EFFECT; STENT; STROKE; SUDDEN DEATH; SURGICAL RISK; SYMPTOM; TREATMENT OUTCOME;

ANTICOAGULANTS; CAROTID STENOSIS; CLINICAL TRIALS AS TOPIC; HUMANS; NEUROSURGICAL PROCEDURES; VASCULAR SURGICAL PROCEDURES;

EID: 33746630559     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2006.00047.x     Document Type: Review

References (52)

1. Lovett JK, Coull AJ, Rothwell PM: Oxford Vascular Study. Early risk of recurrence by subtype of ischemic stroke in population -based incidence studies. Neurology 2004; 62: 569-73.
2. Fairhead JF, Mehta Z, Rothwell PM: Population-based study of delays in carotid imaging and surgery and the risk of recurrent stroke. Neurology 2005; 65: 371-5.
3. Engelter S, Lyrer P: Anti platelet therapy for preventing stroke and other vascular events after carotid endarterectomy. Cochrane Database Syst Rev 2003 CD001458.
4. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both or neither among 19435 patients with acute ischaemic stroke. Lancet 1997; 349: 1569-81.
5. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 1997; 349: 1641-9.
6. Diener HC, Bogousslavsky J, Brass LM, on behalf of the MATCH investigators. et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischemic attack in high-risk patients (MATCH): Randomised double-blind, placebo-controlled trial. Lancet 2004; 364: 331-7.
7. Markus HS, Droste DW, Kaps M et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: The Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 2005; 111: 2233-40.
8. Kennedy J, Eliasziw M, Hill MD, Buchanan AM: The Fast Assessment of Stroke and Transient Ischemic Attack to prevent Early Recurrence (FASTER) Trial. Semin Cerebrovasc Dis Stroke 2003; 3: 25-30.
9. Rothwell PM, Buchan A, Johnston SC: Recent advances in the management of transient ischaemic attacks and minor ischaemic strokes. Lancet Neurol 2006; 5: 323-31.
10. Leonardi-Bee J, Bath PM, Bousser MG, Dipyridamole in Stroke Collaboration (DISC) et al. Dipyridamole for preventing recurrent ischemic stroke and other vascular events: A meta-analysis of individual patient data from randomized controlled trials. Stroke 2005; 36: 162-8.
11. Chimowitz MI, Lynn MJ, Howlett-Smith H, Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005; 352: 1305-16.
12. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk patients: A randomised placebo-controlled trial. Lancet 2002; 360: 722.
13. Collins R, Armitage J, Parish S, Sleight P, Peto R, Heart Protection Study Collaborative Group: Effects of cholesterol lowering with Simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high risk conditions. Lancet 2004; 363: 757-67.
14. Waters DD, Schwartz GG, Olsson AG, MIRACL Study Investigators et al. Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: A Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy. Circulation 2002; 106: 1690-5.
15. Amarenco P, Bogousslavsky J, Callahan AS, SPARCL Investigators et al. Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study. Cerebrovasc Dis 2003; 16: 389-95.
16. Van der Grond J, Balm R, Kappelle LJ, Eikelboom BC, Mali MP: Cerebral metabolism of patients with stenosis or occlusion of the internal carotid artery. Stroke 1995; 26: 822-28.
17. Rothwell PM, Howard SC, Spence JD, Carotid Endarterectomy Trialists' Collaboration: Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease. Stroke 2003; 34: 2583-90.
18. Rothwell PM, Eliasziw M, Gutnikov SA, Carotid Endarterectomy Trialists' Collaboration et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003; 361: 107-16.
19. North American Symptomatic Carotid Endarterectomy Trial Collaborators: Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med 1998; 339: 1415-25.
20. European Carotid Surgery Trialists Collaborative Group: Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998; 351: 1379-87.
21. Rothwell PM, Gutnikov SA, Warlow CP: ECST: re-analysis of the final results of the European Carotid Surgery Trial. Stroke 2003; 34: 514-23.
22. Ascher E, Markevich N, Hingorani A, Kallakuri S: Pseudo-occlusions of the internal carotid artery: A rationale for treatment on the basis of a modified duplex scan protocol. J Vasc Surg 2002; 35: 340-50.
23. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ, Carotid Endarterectomy Trialists Collaboration Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004; 363: 915-24.
24. Bond R, Rerkasem K, Cuffe R, Rowell PM: A systematic review of the associations between age and sex and the operative risks of carotid endarterectomy. Cerebrovasc Dis 2005; 20: 69-77.
25. Johnston SC, Gress DR, Browner WS, Sidney S: Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000; 284: 2901-6.
26. Rothwell PM, Giles MF, Flossmann E et al. A simple score (ABCD) to identify individuals at high early risk of stroke after a transient ischaemic attack. Lancet 2005; 366: 29-36.
27. Hill MD, Yiannakoulias N, Jeerakathil T, Svenson LW, Schopflocher DP: The high risk of stroke immediately after transient ischemic attack: A population-based study. Neurology 2004; 62: 2015-20.
28. Rothwell PM, Gibson R, Warlow CP: The interrelation between plaque surface morphology, degree of stenosis and the risk of ischaemic stroke in patients with symptomatic carotid stenosis. Stroke 2000; 31: 615-21.
29. Rothwell PM, Gutnikov SA, Eliasziw M, Warlow CP, Barnett HJM: Sex difference in effect of time from symptoms to surgery on benefit from endarterectomy for transient ischaemic attack and non-disabling stroke. Stroke 2004; 35: 2855-61.
30. Bond R, Rerkasem K, Rothwell PM: A systematic review of the risks of carotid endarterectomy in relation to the clinical indication and the timing of surgery. Stroke 2003; 34: 2290-301.
31. Fairhead JF, Rothwell PM: The need for urgency in identification and treatment of symptomatic carotid stenosis is already established. Cerebrovasc Dis 2005; 19: 355-58.
32. Schulz UGR, Rothwell PM: Sex differences in the angiographic and gross pathological appearance of carotid atherosclerotic plaques. Neurol Sci 2001; 187 (Suppl. 1): S127.
33. Rantner B, Pavelka M, Posch L, Schmidauer C, Fraedrich G: Carotid endarterectomy after ischemic stroke -is there a justification for delayed surgery? Eur J Vasc Endovasc Surg 2005; 30: 36-40.
34. Rothwell PM: Can overall results of clinical trials be applied to all patients? Lancet 1995; 345: 1616-9.
35. Rothwell PM, Warlow CP, on behalf of the ECST Collaborators Prediction of benefit from carotid endarterectomy in individual patients: A risk-modelling study. Lancet 1999; 353: 2105-10.
36. Rothwell PM, Mehta Z, Howard SC, Gutnikov SA, Warlow CP: From subgroups to individuals: General principles and the example of carotid endartectomy. Lancet 2005; 365: 256-65.
37. Markus HS, MacKinnon A: Asymptomatic embolization detected by Doppler ultrasound predicts stroke risk in symptomatic carotid artery stenosis. Stroke 2005; 36: 971-5.
38. Markus HS: Can microemboli on transcranial Doppler identify patients at increased stroke risk? Nat Clin Pract Cardiovasc Med 2006; 3: 246-7.
39. Markus H, Cullinane M: Severely impaired cerebrovascular reactivity predicts stroke and TIA risk in patients with carotid artery stenosis and occlusion. Brain 2001; 124: 457-67.
40. Silvestrini M, Vernieri F, Pasqualetti P: Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. JAMA 2000 26; 283: 2122-7.
41. Davies JR, Rudd JH, Fryer TD et al. Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke 2005; 36: 2642-7.
42. Takaya N, Yuan C, Chu B et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: A prospective assessment with MRI-initial results. Stroke 2006; 37: 818-23.
43. Dotter CT, Judkins MP, Rosch J: Nonoperative treatment of arterial occlusive disease: A radiologically facilitated technique. Radiol Clin North Am 1967; 5: 531-42.
44. CAVATAS Investigators: Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): A randomised trial. Lancet 2001; 357: 1729-37.
45. Naylor AR, London NJ, Bell PR: Carotid and Vertebral Artery Transluminal Angioplasty Study. Lancet 1997; 349: 1324-5.
46. Alberts MJ for the Publications Committee of the WALLSTENT: Results of a multicentre prospective randomised trial of carotid artery stenting vs. carotid endarterectomy. Stroke 2001; 32: 325.
47. Brooks WH, McClure RR, Jones MR et al. Carotid angioplasty and stenting versus carotid endarterectomy: Randomized trial in a community hospital. J Am Coll Cardiol 2001; 38: 1589-95.
48. Yadav JS, Wholey MH, Kuntz RE et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004; 351: 1493-1501.
49. Reimers B, Corvaja N, Moshiri S et al. Cerebral protection with filter devices during carotid artery stenting. Circulation 2001; 104: 12-15.
50. Ringleb P, Kunze A, Allenberg J et al. The Stent-Supported Percutaneous Angioplasty of the Carotid Artery vs. Endarterectomy Trail. Cerebrovasc Dis 2004; 18: 66-8.
51. EVA-3S Investigators. Carotid angioplasty and stenting with and without cerebral protection: Clinical alert from the Endarterectomy versus Angioplasty in Patients with Symptomatic Severe carotid Stenosis (EVA-3S) trial. Stroke 2004; 35: E18-e21.
52. Rerkasem K, Bond R, Rothwell PM: Local versus general anaesthesia for carotid endarterectomy. Cochrane database Syst Rev 2004: CD000126.